Investigation of Trends in the Research on Transferrin Receptor-Mediated Drug Delivery via a Bibliometric and Thematic Analysis
- PMID: 36559067
- PMCID: PMC9788388
- DOI: 10.3390/pharmaceutics14122574
Investigation of Trends in the Research on Transferrin Receptor-Mediated Drug Delivery via a Bibliometric and Thematic Analysis
Abstract
This study systematically reviews and characterizes the existing literature on transferrin/transferrin receptor-mediated drug delivery. Transferrin is an iron-binding protein. It can be used as a ligand to deliver various proteins, genes, ions, and drugs to the target site via transferrin receptors for therapeutic or diagnostic purposes via transferrin receptors. This study is based on a cross-sectional bibliometric analysis of 583 papers limited to the subject areas of pharmacology, toxicology, and pharmaceutics as extracted from the Scopus database in mid-September 2022. The data were analyzed, and we carried out a performance analysis and science mapping. There was a significant increase in research from 2018 onward. The countries that contributed the most were the USA and China, and most of the existing research was found to be from single-country publications. Research studies on transferrin/transferrin receptor-mediated drug delivery focus on drug delivery across the blood-brain barrier in the form of nanoparticles. The thematic analysis revealed four themes: transferrin/transferrin receptor-mediated drug delivery to the brain, cancer cells, gene therapy, nanoparticles, and liposomes as drug delivery systems. This study is relevant to academics, practitioners, and decision makers interested in targeted and site-specific drug delivery.
Keywords: bibliometric analysis; drug delivery; performance analysis; scientific mapping; thematic analysis; transferrin receptor.
Conflict of interest statement
The authors declare no conflict of interest. The items expressed in this article are personal and do not represent those of the Lupin Research Park.
Figures
References
-
- Mills J.K., Needham D. Targeted Drug Delivery. Expert Opin. Ther. Pat. 1999;9:1499–1513. doi: 10.1517/13543776.9.11.1499. - DOI
-
- Daniels T.R., Bernabeu E., Rodríguez J.A., Patel S., Kozman M., Chiappetta D.A., Holler E., Ljubimova J.Y., Helguera G., Penichet M.L. The Transferrin Receptor and the Targeted Delivery of Therapeutic Agents against Cancer. Biochim. Biophys. Acta-Gen. Subj. 2012;1820:291–317. doi: 10.1016/j.bbagen.2011.07.016. - DOI - PMC - PubMed
-
- Callens C., Moura I.C., Lepelletier Y., Coulon S., Renand A., Dussiot M., Ghez D., Benhamou M., Monteiro R.C., Bazarbachi A., et al. Recent Advances in Adult T-Cell Leukemia Therapy: Focus on a New Anti-Transferrin Receptor Monoclonal Antibody. Leukemia. 2008;22:42–48. doi: 10.1038/sj.leu.2404958. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
